Bilcare Board Meeting Scheduled for Nov'26 to Consider Q2 Results
Bilcare Ltd 路 Intimation 路 03 Nov 2026, 5:30 am
Bilcare Board Meeting Scheduled for Nov'26 to Consider Q2 Results Bilcare Limited has scheduled a meeting of its Board of Directors on 3rd Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half year ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed from 1st Oct'26 and will remain shut until 48 hours following the official declaration of the financial results.
Original exchange filing (PDF)
More announcements from Bilcare Ltd
- The Board of Directors has approved the Financial Results for quarter and half year ended September 30, 2026 路 04 Nov 2026
- The Board of Directors of Bilcare Limited in their meeting held on Tuesday, 03 November 2026 have approved and taken on record Standalone and Consolidated Unaudited Financial Results of .... 路 04 Nov 2026
- Update on Voluntary winding up of Bilcare INC -US 路 20 Oct 2026
- Change in Designation of Mr. Mohan Bhandari and Ms Kavita Bhansali 路 15 Oct 2026
- Voting Results of 39th Annual General Meeting and Scrutinizers Reports 路 30 Sept 2026
- Bilcare Limited has informed the exchange about Proceeding of 39th Annual General Meeting held on 26 September 2026 路 27 Sept 2026
- Bilcare Limited has submitted to Stock Exchange the Corrigendum to item No. 4 of the Notice of the 39th Annual General Meeting 路 24 Sept 2026
- Bilcare Limited has submitted to Stock Exchange the Corrigendum to Item No. 4 of the Notice of the 39th Annual General Meeting 路 24 Sept 2026
